Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001250853-13-000150)

Filing Details

Accession Number:: 0001250853-13-000150
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-13 12:43:18
Reporting Period:: 2013-12-12

Filing Date:: 2013-12-13
Accepted Time:: 2013-12-13 12:43:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561743	Kindred Biosciences Inc.	KIN	Pharmaceutical Preparations (2834)	461160142

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1593868	Kevin Schultz	C/O Kindred Biosciences, Inc. 1499 Bayshore Highway, Suite 226 Burlingame CA 94010	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-12	4,000	$7.00	4,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares were purchased through a directed share program in connection with the Issuer's initial public offering.